Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride
95%
- Product Code: 122306
CAS:
124655-63-6
| Molecular Weight: | 205.68 g./mol | Molecular Formula: | C₉H₁₆ClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09032985 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. It is particularly valuable in the development of drugs targeting neurological disorders, as its structure can be modified to interact with specific receptors in the brain. Additionally, it is utilized in the creation of compounds with potential anti-inflammatory and analgesic properties. Its hydrochloride form enhances solubility, making it suitable for formulation in preclinical studies. Researchers also explore its role in designing novel therapeutic agents for conditions like chronic pain and neurodegenerative diseases.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €377.26 |
+
-
|
Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. It is particularly valuable in the development of drugs targeting neurological disorders, as its structure can be modified to interact with specific receptors in the brain. Additionally, it is utilized in the creation of compounds with potential anti-inflammatory and analgesic properties. Its hydrochloride form enhances solubility, making it suitable for formulation in preclinical studies. Researchers also explore its role in designing novel therapeutic agents for conditions like chronic pain and neurodegenerative diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :